-
1
-
-
18744433336
-
A clinical analysis of risk factors in women operated because of endometrial cancer
-
Lapinska S., Olszewski J., Makarewicz H., Emerich J., and Debniak J. A clinical analysis of risk factors in women operated because of endometrial cancer. Ginekol Pol 69 (1998) 252-257
-
(1998)
Ginekol Pol
, vol.69
, pp. 252-257
-
-
Lapinska, S.1
Olszewski, J.2
Makarewicz, H.3
Emerich, J.4
Debniak, J.5
-
2
-
-
33745368215
-
Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease
-
Weiss J.M., Saltzman B.S., Doherty J.A., et al. Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Am J Epidemiol 164 (2006) 56-62
-
(2006)
Am J Epidemiol
, vol.164
, pp. 56-62
-
-
Weiss, J.M.1
Saltzman, B.S.2
Doherty, J.A.3
-
3
-
-
1342293111
-
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas
-
Nishioka Y., Kobayashi K., Sagae S., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91 (2000) 612-615
-
(2000)
Jpn J Cancer Res
, vol.91
, pp. 612-615
-
-
Nishioka, Y.1
Kobayashi, K.2
Sagae, S.3
-
4
-
-
33749529723
-
Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population
-
Sugimoto M., Yoshida S., Kennedy S., Deguchi M., Ohara N., and Maruo T. Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J Soc Gynecol Investig 13 (2006) 523-529
-
(2006)
J Soc Gynecol Investig
, vol.13
, pp. 523-529
-
-
Sugimoto, M.1
Yoshida, S.2
Kennedy, S.3
Deguchi, M.4
Ohara, N.5
Maruo, T.6
-
5
-
-
33748527496
-
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
-
Kubben F.J., Sier C.F., Meijer M.J., et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 95 (2006) 744-751
-
(2006)
Br J Cancer
, vol.95
, pp. 744-751
-
-
Kubben, F.J.1
Sier, C.F.2
Meijer, M.J.3
-
6
-
-
0033061405
-
Matrix metalloproteinases and their inhibitors
-
Kugler A. Matrix metalloproteinases and their inhibitors. Anticancer Res 19 (1999) 1589-1592
-
(1999)
Anticancer Res
, vol.19
, pp. 1589-1592
-
-
Kugler, A.1
-
7
-
-
0030717692
-
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions
-
Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74 (1997) 111-122
-
(1997)
Eur J Cell Biol
, vol.74
, pp. 111-122
-
-
Gomez, D.E.1
Alonso, D.F.2
Yoshiji, H.3
Thorgeirsson, U.P.4
-
8
-
-
0028598887
-
Protease inhibitors: role and potential therapeutic use in human cancer
-
DeClerck Y.A., and Imren S. Protease inhibitors: role and potential therapeutic use in human cancer. Eur J Cancer 30A (1994) 2170-2180
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 2170-2180
-
-
DeClerck, Y.A.1
Imren, S.2
-
9
-
-
0028140295
-
Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1
-
Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86 (1994) 299-304
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 299-304
-
-
Khokha, R.1
-
10
-
-
0028104790
-
Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
-
Montgomery A.M., Mueller B.M., Reisfeld R.A., Taylor S.M., and DeClerck Y.A. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54 (1994) 5467-5473
-
(1994)
Cancer Res
, vol.54
, pp. 5467-5473
-
-
Montgomery, A.M.1
Mueller, B.M.2
Reisfeld, R.A.3
Taylor, S.M.4
DeClerck, Y.A.5
-
11
-
-
0034181347
-
Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion
-
POC, Rhys-Evans P., Modjtahedi H., Court W., Box G., and Eccles S. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 86 (2000) 307-317
-
(2000)
Int J Cancer
, vol.86
, pp. 307-317
-
-
POC1
Rhys-Evans, P.2
Modjtahedi, H.3
Court, W.4
Box, G.5
Eccles, S.6
-
12
-
-
0027443276
-
Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues
-
Lokeshwar B.L., Selzer M.G., Block N.L., and Gunja-Smith Z. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res 53 (1993) 4493-4498
-
(1993)
Cancer Res
, vol.53
, pp. 4493-4498
-
-
Lokeshwar, B.L.1
Selzer, M.G.2
Block, N.L.3
Gunja-Smith, Z.4
-
13
-
-
0026568011
-
Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
-
Hayakawa T., Yamashita K., Tanzawa K., Uchijima E., and Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298 (1992) 29-32
-
(1992)
FEBS Lett
, vol.298
, pp. 29-32
-
-
Hayakawa, T.1
Yamashita, K.2
Tanzawa, K.3
Uchijima, E.4
Iwata, K.5
-
14
-
-
0035066974
-
Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis
-
Guedez L., McMarlin A.J., Kingma D.W., Bennett T.A., Stetler-Stevenson M., and Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Am J Pathol 158 (2001) 1207-1215
-
(2001)
Am J Pathol
, vol.158
, pp. 1207-1215
-
-
Guedez, L.1
McMarlin, A.J.2
Kingma, D.W.3
Bennett, T.A.4
Stetler-Stevenson, M.5
Stetler-Stevenson, W.G.6
-
15
-
-
0032484529
-
Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression
-
Yoshiji H., Harris S.R., Raso E., et al. Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. Int J Cancer 75 (1998) 81-87
-
(1998)
Int J Cancer
, vol.75
, pp. 81-87
-
-
Yoshiji, H.1
Harris, S.R.2
Raso, E.3
-
16
-
-
0000278421
-
Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis
-
Goss K.J., Brown P.D., and Matrisian L.M. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. Int J Cancer 78 (1998) 629-635
-
(1998)
Int J Cancer
, vol.78
, pp. 629-635
-
-
Goss, K.J.1
Brown, P.D.2
Matrisian, L.M.3
-
17
-
-
0345357726
-
TIMP-1 inhibits apoptosis in breast carcinoma cells via a pathway involving pertussis toxin-sensitive G protein and c-Src
-
Lee S.J., Yoo H.J., Bae Y.S., Kim H.J., and Lee S.T. TIMP-1 inhibits apoptosis in breast carcinoma cells via a pathway involving pertussis toxin-sensitive G protein and c-Src. Biochem Biophys Res Commun 312 (2003) 1196-1201
-
(2003)
Biochem Biophys Res Commun
, vol.312
, pp. 1196-1201
-
-
Lee, S.J.1
Yoo, H.J.2
Bae, Y.S.3
Kim, H.J.4
Lee, S.T.5
-
18
-
-
34247507252
-
TIMP-1 regulates cell proliferation by interacting with the ninth zinc finger domain of PLZF
-
Rho S.B., Chung B.M., and Lee J.H. TIMP-1 regulates cell proliferation by interacting with the ninth zinc finger domain of PLZF. J Cell Biochem 101 (2007) 57-67
-
(2007)
J Cell Biochem
, vol.101
, pp. 57-67
-
-
Rho, S.B.1
Chung, B.M.2
Lee, J.H.3
-
19
-
-
0032545643
-
TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
-
Valente P., Fassina G., Melchiori A., et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 75 (1998) 246-253
-
(1998)
Int J Cancer
, vol.75
, pp. 246-253
-
-
Valente, P.1
Fassina, G.2
Melchiori, A.3
-
20
-
-
0030796263
-
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
-
Ree A.H., Florenes V.A., Berg J.P., Maelandsmo G.M., Nesland J.M., and Fodstad O. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res 3 (1997) 1623-1628
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1623-1628
-
-
Ree, A.H.1
Florenes, V.A.2
Berg, J.P.3
Maelandsmo, G.M.4
Nesland, J.M.5
Fodstad, O.6
-
21
-
-
0036065691
-
Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis
-
Nakopoulou L., Giannopoulou I., Stefanaki K., et al. Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis. J Pathol 197 (2002) 307-313
-
(2002)
J Pathol
, vol.197
, pp. 307-313
-
-
Nakopoulou, L.1
Giannopoulou, I.2
Stefanaki, K.3
-
22
-
-
0842279291
-
Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer
-
Schrohl A.S., Christensen I.J., Pedersen A.N., et al. Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer. Mol Cell Proteomics 2 (2003) 164-172
-
(2003)
Mol Cell Proteomics
, vol.2
, pp. 164-172
-
-
Schrohl, A.S.1
Christensen, I.J.2
Pedersen, A.N.3
-
23
-
-
0035869567
-
Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis
-
Guedez L., Mansoor A., Birkedal-Hansen B., et al. Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood 97 (2001) 1796-1802
-
(2001)
Blood
, vol.97
, pp. 1796-1802
-
-
Guedez, L.1
Mansoor, A.2
Birkedal-Hansen, B.3
-
24
-
-
0033572494
-
Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells
-
Li G., Fridman R., and Kim H.R. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 59 (1999) 6267-6275
-
(1999)
Cancer Res
, vol.59
, pp. 6267-6275
-
-
Li, G.1
Fridman, R.2
Kim, H.R.3
-
25
-
-
0022382006
-
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
-
Docherty A.J., Lyons A., Smith B.J., et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318 (1985) 66-69
-
(1985)
Nature
, vol.318
, pp. 66-69
-
-
Docherty, A.J.1
Lyons, A.2
Smith, B.J.3
-
26
-
-
35448964331
-
Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm
-
Hinterseher I., Krex D., Kuhlisch E., et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm. World J Surg 31 (2007) 2248-2254
-
(2007)
World J Surg
, vol.31
, pp. 2248-2254
-
-
Hinterseher, I.1
Krex, D.2
Kuhlisch, E.3
-
27
-
-
34447101822
-
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease
-
Meijer M.J., Mieremet-Ooms M.A., van Hogezand R.A., Lamers C.B., Hommes D.W., and Verspaget H.W. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 13 (2007) 2960-2966
-
(2007)
World J Gastroenterol
, vol.13
, pp. 2960-2966
-
-
Meijer, M.J.1
Mieremet-Ooms, M.A.2
van Hogezand, R.A.3
Lamers, C.B.4
Hommes, D.W.5
Verspaget, H.W.6
-
28
-
-
33748782786
-
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients
-
Indelicato M., Chiarenza V., Libra M., et al. Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients. J Clin Lab Anal 20 (2006) 173-176
-
(2006)
J Clin Lab Anal
, vol.20
, pp. 173-176
-
-
Indelicato, M.1
Chiarenza, V.2
Libra, M.3
-
29
-
-
70449704623
-
Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis
-
in press
-
Wei JC, Lee HS, Chen WC, Shiu LJ, Yang SF, Wong RH. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis. Ann Rheum Dis in press.
-
Ann Rheum Dis
-
-
Wei, J.C.1
Lee, H.S.2
Chen, W.C.3
Shiu, L.J.4
Yang, S.F.5
Wong, R.H.6
-
30
-
-
0033358525
-
Polymorphic X-chromosome inactivation of the human TIMP1 gene
-
Anderson C.L., and Brown C.J. Polymorphic X-chromosome inactivation of the human TIMP1 gene. Am J Hum Genet 65 (1999) 699-708
-
(1999)
Am J Hum Genet
, vol.65
, pp. 699-708
-
-
Anderson, C.L.1
Brown, C.J.2
-
31
-
-
0031697268
-
Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells
-
Hamasaki T., Hattori T., Kimura G., and Nakazawa N. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells. Urol Res 26 (1998) 371-376
-
(1998)
Urol Res
, vol.26
, pp. 371-376
-
-
Hamasaki, T.1
Hattori, T.2
Kimura, G.3
Nakazawa, N.4
-
32
-
-
0345109257
-
Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma
-
Kugler A., Hemmerlein B., Thelen P., Kallerhoff M., Radzun H.J., and Ringert R.H. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J Urol 160 (1998) 1914-1918
-
(1998)
J Urol
, vol.160
, pp. 1914-1918
-
-
Kugler, A.1
Hemmerlein, B.2
Thelen, P.3
Kallerhoff, M.4
Radzun, H.J.5
Ringert, R.H.6
-
33
-
-
13144277560
-
The expression of MMP-2 and TIMP-2 in patients with colorectal adenocarcinoma invaded to the submucosal and proper muscle layer
-
Mukai M., Sadahiro S., Tokunaga N., et al. The expression of MMP-2 and TIMP-2 in patients with colorectal adenocarcinoma invaded to the submucosal and proper muscle layer. Oncol Rep 5 (1998) 335-340
-
(1998)
Oncol Rep
, vol.5
, pp. 335-340
-
-
Mukai, M.1
Sadahiro, S.2
Tokunaga, N.3
-
34
-
-
0344737030
-
Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms
-
Krex D., Rohl H., Konig I.R., Ziegler A., Schackert H.K., and Schackert G. Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 34 (2003) 2817-2821
-
(2003)
Stroke
, vol.34
, pp. 2817-2821
-
-
Krex, D.1
Rohl, H.2
Konig, I.R.3
Ziegler, A.4
Schackert, H.K.5
Schackert, G.6
-
35
-
-
0035164768
-
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease
-
Hirano K., Sakamoto T., Uchida Y., et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 18 (2001) 748-752
-
(2001)
Eur Respir J
, vol.18
, pp. 748-752
-
-
Hirano, K.1
Sakamoto, T.2
Uchida, Y.3
-
36
-
-
20044383000
-
Promoter activity of human tissue inhibitor of metalloproteinase 2 gene with novel single nucleotide polymorphisms
-
Hegab A.E., Sakamoto T., Uchida Y., et al. Promoter activity of human tissue inhibitor of metalloproteinase 2 gene with novel single nucleotide polymorphisms. Respirology 10 (2005) 27-30
-
(2005)
Respirology
, vol.10
, pp. 27-30
-
-
Hegab, A.E.1
Sakamoto, T.2
Uchida, Y.3
-
37
-
-
41849100005
-
Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
-
Kang S., Zhao X., Xing H., et al. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis. Environ Mol Mutagen 49 (2008) 226-231
-
(2008)
Environ Mol Mutagen
, vol.49
, pp. 226-231
-
-
Kang, S.1
Zhao, X.2
Xing, H.3
-
38
-
-
32544438318
-
Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma
-
Roca F., Mauro L.V., Morandi A., et al. Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma. J Surg Oncol 93 (2006) 151-160
-
(2006)
J Surg Oncol
, vol.93
, pp. 151-160
-
-
Roca, F.1
Mauro, L.V.2
Morandi, A.3
-
39
-
-
32644482152
-
The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer
-
O-Charoenrat P., and Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol 42 (2006) 257-267
-
(2006)
Oral Oncol
, vol.42
, pp. 257-267
-
-
O-Charoenrat, P.1
Khantapura, P.2
-
40
-
-
34249931241
-
Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans
-
Vairaktaris E., Yapijakis C., Yiannopoulos A., et al. Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep 17 (2007) 963-968
-
(2007)
Oncol Rep
, vol.17
, pp. 963-968
-
-
Vairaktaris, E.1
Yapijakis, C.2
Yiannopoulos, A.3
-
41
-
-
43449106192
-
Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population
-
Yang L., Gu H.J., Zhu H.J., et al. Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population. Eur J Surg Oncol 34 (2008) 636-641
-
(2008)
Eur J Surg Oncol
, vol.34
, pp. 636-641
-
-
Yang, L.1
Gu, H.J.2
Zhu, H.J.3
|